I've seen it. I've heard the arguments. Blah blah blah. Institutions, who can also read science reports and analyst reports, won't touch the stock. AMRN management won't touch it with their own money. The market cap is well below $300m. This all speaks volumes. But hey, if you believe in it, go for it. If you believe in it, more power to ya. I just believe the truth is that it is very very risky and the outcome completely uncertain. Of course it won't be stopped at interim, but will it be successful in the end? Perhaps. Perhaps not. But when the "perhaps not" means the stock goes to 20 cents, it should get your attention.
You still haven't explained why several institutions with long, close relationships with AMRN exited the stock and institutional ownership continues to go down every quarter. I do believe that removing the huge financial overhang and diluting already might, at this point, be beneficial. No one is gonna touch a stock that is on the brink of being out of money when everyone and their dog knows they need to raise cash soon. This should have been taken care of EONS ago so that focus could have shifted to REDUCE-IT, but our crackerjack management team said no.
News 
Market Data 
Discover 
